CAI
NASD Caris Life Sciences, Inc.$28.30 ↑ +0.00 (+0.00%) Trading Up from the previous close of $28.30, $0.67 below the day’s high of $28.97
- YTD change
- +4.89%
- vs 20-day SMA
- -0.98%
- vs 200-day SMA
- +33.46%
Price ranges
Price & Performance
+9.29 (+48.87%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 33.4% away from all-time highs of $42.50
- CAI is up 5% since the beginning of the year
- CAI is down 5% over the past 12 months
- CAI is up 14% over the past 1 month
- 11% of all CAI investors are betting against CAI
CAI reads neutral: price sits above one of the two key moving averages, the 12-month move is -11.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.09
- Last 5 days
- -12.30%
- vs 8-day SMA
- -9.31%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.